Smartee Chief Scientist Prof. Gang Shen Recognized Among World's Top 2% Scientists for Orthodontic Contributions

Smartee Denti-Technology today announced that Professor Gang Shen, its Chief Scientist and Executive President of TaiKang ...

The Challenges of Root Caries Diagnosis and Treatment

For dental professionals, managing root caries means mastering risk assessment, patient education, and new tools like silver ...
Good News Network

2-in-1 Inhaler Reduces Asthma Attacks in Children by 45% Shows New Study

Findings could redefine the treatment for millions of children worldwide with asthma, after this comparison of two types of ...
Healio

FDA approves first once-daily oral treatment for acromegaly

The FDA has approved paltusotine, a selectively targeted somatostatin receptor type 2 nonpeptide agonist, for first-line treatment of certain patients with acromegaly, Crinetics Pharmaceuticals ...
Medscape

Updated ESC Guidelines Support Newer, Less Invasive Treatment Options for Valvular Heart Disease

Updates to the European Society of Cardiology valvular heart disease guidelines reflect new data from several key studies ...
AFP

Vertex Announces Results from Phase 2 Study of VX-993 for the Treatment of Acute Pain

VX-993 was generally safe and well tolerated at all doses studied in the trial. The overall incidence of adverse events on VX-993 was similar to placebo. The majority of the AEs were mild or moderate ...
The American Journal of Managed Care

Individualizing Treatment for Patients With AML Unfit for Intensive Chemo

Management of newly diagnosed acute myeloid leukemia (AML) in patients deemed unfit for intensive chemotherapy is undergoing rapid transformation toward highly individualized regimens. The combination ...
BioWorld

First-in-class oral GLP-2 for short bowel syndrome presented

Glucagon-like peptide-2 (GLP-2) is an endogenous hormone released by intestinal L-cells that supports gastrointestinal (GI) function and nutrient absorption. However, its therapeutic use is limited by ...
The American Journal of Managed Care

Leucovorin Treatment Expansion for Autism Symptoms Under FDA Review

Leucovorin, a calcium tablet approved to treat colorectal cancer and anemia, is currently undergoing FDA review to treat patients with cerebral folate deficiency (CFD)—a condition observed to cause ...
BioPharma Dive

FDA, in unusual step, aims to repurpose old GSK drug as autism treatment

After reviewing existing published literature, the agency initiated the approval of Wellcovorin — which GSK stopped selling ...
ESPN

Scotty Bowman, Ron Francis make Penguins' Hall of Fame class

PITTSBURGH -- Scotty Bowman and Ron Francis headline the Pittsburgh Penguins' Hall of Fame class of 2025. Bowman, the NHL's all-time winningest coach, and Francis, the league's fifth all-time leading ...
MedPage Today on MSN

First Approval of Eyeglass Lenses for Children With Myopia

The FDA granted a first-ever market authorization for eyeglass lenses for children with myopia, or nearsightedness, the agency announced Thursday. The approval of the Essilor Stellest lenses with ...